Northville, MI, United States of America

Rose Ackermann

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Inventor Rose Ackermann in Lipoprotein Research

Introduction

Rose Ackermann, an accomplished inventor based in Northville, MI, has made significant contributions to the field of lipoprotein research through her innovative inventions. With a total of seven patents to her name, Ackermann is recognized for her work in the treatment and prevention of dyslipidemic diseases. Her latest patents showcase her dedication to advancing medical science and improving healthcare outcomes.

Latest Patents

One of Ackermann's notable recent patents is focused on lipoprotein complexes and their manufacturing processes. This patent outlines the use of lipoprotein populations in treating and preventing dyslipidemic diseases, disorders, and conditions. It further delves into the recombinant expression and purification of apolipoproteins, alongside the production of lipoprotein complexes through thermal cycling-based methods. This groundbreaking research has the potential to greatly enhance therapeutic strategies for individuals suffering from lipid-related health issues.

Career Highlights

Throughout her career, Rose Ackermann has worked with renowned companies, including Cerenis Therapeutics Holding S.A. and Abionyx Pharma S.A. These experiences have undoubtedly enriched her knowledge and expertise in lipoprotein-related innovations. Ackermann's passion for research and invention has led her to refine existing treatments and develop novel solutions in the healthcare industry.

Collaborations

Collaboration has been a vital aspect of Rose Ackermann’s career. She has worked closely with esteemed colleagues such as Jean-Louis Henri Dasseux and Daniela Carmen Oniciu. These partnerships have fostered a creative environment for innovation and have played a crucial role in the successful development of her patents. The synergy achieved through these collaborations enhances the potential impact of her research on the medical field.

Conclusion

Rose Ackermann's dedication to innovation in the realm of lipoprotein research has led to significant advancements in the treatment of dyslipidemic diseases. Her seven patents are a testament to her inventiveness and commitment to improving health outcomes. As the field continues to evolve, Ackermann's contributions will undoubtedly play a crucial role in shaping the future of medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…